Developer docs
API playgroundTry for free, no card

Search company profiles

ENGAIN

Full company profile

uuid000hmog

Namestring
ENGAIN
Legal namestring
주식회사 엔게인
Websiteurl
engain.co.kr
Company typeenum
Private
Founded yearint
2011
Descriptiontext

ENGAIN (주식회사 엔게인) is a privately held South Korean medical device company founded in December 2011 that specializes in the research, development, and manufacturing of medical devices built on proprietary biocompatible polymer synthetic materials. The company operates from its headquarters in Hwaseong-si, Gyeonggi-do, with manufacturing at KGMP-certified facilities in Dongtan and Sangweon, and employs between 11 and 50 people. It is led by CEO Go Young-guk (고영국) and has raised capital through more than 20 rights offerings between 2020 and 2026, indicating it is in a growth-financing phase rather than operating at scale.

ENGAIN's product portfolio is organized around three therapeutic pillars plus medical consumables. The embolization franchise includes EGgel (MFDS Class 3 approved 2016), EGbead (2017), and KIPZA fast-dissolving microparticles, all based on gelatin-based biomaterials used for vascular embolization procedures. The wound closure franchise centers on EGglue (MFDS Class 3 approved 2020) and Easyglue, both N-Butyl Cyanoacrylate (n-BCA) based skin adhesives. The varicose vein treatment franchise is anchored by NUVENA, a non-thermal non-tumescent (NTNT) adhesive closure system that received MFDS market approval on January 6, 2026. Adjacent medical consumables include Soft Fix PLUS drainage tube fixators, Bougie-36 surgical guides, and LAPA FIX laparoscopic instruments. The company also maintains a research direction in a color-change sensing diagnostic platform that is not yet commercialized.

ENGAIN generates revenue through direct B2B sales of medical devices to hospitals and healthcare facilities, with the majority of its confirmed customer base concentrated in Seoul's top 5 general hospitals as of 2019. It sells primarily through an enterprise field sales motion supplemented by a customer satisfaction hotline, and exports products to international markets including the Middle East and Europe following its 2018 overseas launch of EGgel. The company's competitive position rests on in-house polymer chemistry capabilities, accumulated MFDS Class 1, 2, and 3 regulatory approvals, ISO 13485:2016 and KGMP quality certifications, and a vertically integrated R&D-to-manufacturing model. Pricing is negotiated individually per institutional account and is not publicly disclosed.

Short descriptiontext

ENGAIN is a South Korean medical device company founded in 2011 that develops and manufactures biocompatible polymer-based embolization agents, skin adhesives, and varicose vein treatment systems, selling directly to hospitals domestically and exporting to international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGyeongju, South Korea
HQ citystring
Gyeongju
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular embolization devices, medical adhesives, varicose vein treatment, biocompatible polymers, interventional medical devices
Industry1 code
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Interventional Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

ENGAIN generates revenue through the sale of medical devices including embolic agents, medical adhesives, wound closure products, and varicose vein treatment systems. Products are sold domestically in Korea and exported internationally. The company operates as both manufacturer and seller with in-house capabilities.

engain.co.kr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1KIPZA
Description

Quick-dissolving microparticles for embolization therapy, 100-4,000 μm in 5 size ranges, dissolves within 24 hours

engain.co.kr
+4 more records
Core offering1 text field

ENGAIN researches, develops, and manufactures proprietary biocompatible polymer-based medical devices for interventional procedures, sold directly to hospitals and healthcare facilities. Its product portfolio covers vascular embolization agents (EGgel, KIPZA, EGbead), medical skin adhesives (EGglue, EasyGlue), the NUVENA NTNT varicose vein treatment system, and single-use medical consumables (Soft Fix PLUS, Bougie-36, LAPA FIX). All products are produced in-house at KGMP-certified facilities and protected by MFDS regulatory approvals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced patient recovery time with NTNT (Non-thermal, Non-tumescent) varicose vein treatment
+1 more record
Product overview1 text field

ENGAIN is a medical device research, development, and manufacturing company specializing in biocompatible polymer synthetic materials. The product portfolio consists of three main therapeutic areas: (1) Embolization products including EGgel, KIPZA, and EGbead for vascular embolization procedures, (2) Medical adhesives including EGglue and Easyglue for skin and epidermal closure, and (3) Varicose vein treatment systems including NUVENA using NTNT (Non-thermal, Non-tumescent) adhesive technology. Additionally, the company produces single-use medical consumables including drain tube fixation devices (Soft Fix PLUS), Bougie-36 surgical guides, and LAPA FIX laparoscopic instruments. All products are developed using proprietary polymer chemistry technology and manufactured in-house at KGMP-certified facilities.

Product and service9 records
1EGgel (Vascular Embolization Prosthesis)
CategoryVascular Embolization Devices
Description

Gelatin-based embolic prosthesis in dry powder form for intravascular embolization procedures, available in 8 particle size options from 50 to 4,000 μm in both particle and cube forms, supplied in 20 mL transparent syringes with 100 mg or 300 mg doses. For use by interventional radiologists and vascular surgeons in hospitals.

2KIPZA (Fast-Dissolving Embolic Microparticles)
CategoryVascular Embolization Devices
Description

Fast-degradable microparticle embolic material for vascular embolization that biodegrades within 24 hours, available in 5 size ranges from 100 to 4,000 μm in 20 mL syringes at 100, 130, or 160 mg doses. For use by interventional specialists in hospitals.

3EGbead (Vascular Embolization Microbead)
CategoryVascular Embolization Devices
Description

Fast-degradable microbead embolic material for vascular embolization procedures in 2 size ranges from 100 to 500 μm, supplied in 20 mL transparent syringes with 100, 200, or 300 mg doses. For use by interventional radiologists in hospitals.

4EGglue (Medical Skin Adhesive)
CategoryMedical Adhesives
Description

N-Butyl Cyanoacrylate (n-BCA) based skin adhesive for epidermal closure featuring biocompatibility and strong tensile strength, supplied as a 0.7 mL ampule with applicator in Soft/Narrow tip variants and dyed purple for easy identification. For use by clinicians in hospitals and clinics.

5EasyGlue (이지글루) Medical Skin Adhesive
CategoryMedical Adhesives
Description

Medical skin adhesive product for wound closure and skin adhesion applications, launched in October 2021 as a companion offering to EGglue.

6NUVENA Varicose Vein Treatment System
CategoryVaricose Vein Treatment Systems
Description

N-Butyl Cyanoacrylate (n-BCA) based lower extremity varicose vein treatment system with integrated adhesive and injection kit. Uses NTNT (Non-thermal, Non-tumescent) treatment method, developed with 100% domestic Korean technology, providing precision adhesive delivery for consistent occlusion effects. For use by vascular surgeons and interventional phlebologists in hospitals.

7Soft Fix PLUS (Drain Tube Fixator)
CategoryMedical Consumables
Description

Silicone and hydrocolloid drain tube fixation device with one-touch locking mechanism to prevent tube twisting, sized for 7-12 Fr drainage tubes with 108 x 48 mm dressing, 25 pieces per box, sterile single-use medical device. For use in hospital surgical and drainage procedures.

8Bougie-36 Surgical Guide
CategoryMedical Consumables
Description

Invasive disposable medical guide made of medical silicone, used during gastrectomy to confirm stomach position and guide surgical site marking. Class 2 device, 10 pieces per box, sterile. For use by surgeons in hospitals.

9LAPA FIX Laparoscopic Instrument
CategoryMedical Consumables
Description

Disposable general endoscope instrument made of medical silicone that provides surgical space and visibility during laparoscopic procedures by lifting organs against the diaphragm using suction force. Available in 2 sizes (045, 055), 10 pieces per box. For use by laparoscopic surgeons in hospitals.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers4 records
TypeBroad incumbent
TypeDirect peer
Description

Merit Medical is a leading global manufacturer of embolization particles, microcatheters, and vascular interventional devices. Directly comparable to ENGAIN's EGgel/EGbead/KIPZA embolization product line serving interventional radiology procedures.

TypeBroad incumbent
Description

Boston Scientific acquired BTG and now markets global embolization solutions (Embozene, Onyx). Competes broadly with ENGAIN's vascular embolization portfolio across multiple geographies with established clinical evidence and distribution.

4Cook Medical
TypeDirect peer
Description

Cook Medical manufactures embolization coils, particles, and vascular devices used in interventional radiology. Directly competes with ENGAIN's EGgel/KIPZA/EGbead embolic products in hospital interventional settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ENGAIN

Interventional Medical Devicesengain.co.kr

ENGAIN is a South Korean medical device company founded in 2011 that develops and manufactures biocompatible polymer-based embolization agents, skin adhesives, and varicose vein treatment systems, selling directly to hospitals domestically and exporting to international markets.

What ENGAIN does

ENGAIN (주식회사 엔게인) is a privately held South Korean medical device company founded in December 2011 that specializes in the research, development, and manufacturing of medical devices built on proprietary biocompatible polymer synthetic materials. The company operates from its headquarters in Hwaseong-si, Gyeonggi-do, with manufacturing at KGMP-certified facilities in Dongtan and Sangweon, and employs between 11 and 50 people. It is led by CEO Go Young-guk (고영국) and has raised capital through more than 20 rights offerings between 2020 and 2026, indicating it is in a growth-financing phase rather than operating at scale.

ENGAIN's product portfolio is organized around three therapeutic pillars plus medical consumables. The embolization franchise includes EGgel (MFDS Class 3 approved 2016), EGbead (2017), and KIPZA fast-dissolving microparticles, all based on gelatin-based biomaterials used for vascular embolization procedures. The wound closure franchise centers on EGglue (MFDS Class 3 approved 2020) and Easyglue, both N-Butyl Cyanoacrylate (n-BCA) based skin adhesives. The varicose vein treatment franchise is anchored by NUVENA, a non-thermal non-tumescent (NTNT) adhesive closure system that received MFDS market approval on January 6, 2026. Adjacent medical consumables include Soft Fix PLUS drainage tube fixators, Bougie-36 surgical guides, and LAPA FIX laparoscopic instruments. The company also maintains a research direction in a color-change sensing diagnostic platform that is not yet commercialized.

ENGAIN generates revenue through direct B2B sales of medical devices to hospitals and healthcare facilities, with the majority of its confirmed customer base concentrated in Seoul's top 5 general hospitals as of 2019. It sells primarily through an enterprise field sales motion supplemented by a customer satisfaction hotline, and exports products to international markets including the Middle East and Europe following its 2018 overseas launch of EGgel. The company's competitive position rests on in-house polymer chemistry capabilities, accumulated MFDS Class 1, 2, and 3 regulatory approvals, ISO 13485:2016 and KGMP quality certifications, and a vertically integrated R&D-to-manufacturing model. Pricing is negotiated individually per institutional account and is not publicly disclosed.

ENGAIN firmographics

Firmographics
Name
ENGAIN
Legal name
주식회사 엔게인
Website
https://engain.co.kr
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
ENGAIN is a South Korean medical device company founded in 2011 that develops and manufactures biocompatible polymer-based embolization agents, skin adhesives, and varicose vein treatment systems, selling directly to hospitals domestically and exporting to international markets.
Ownership category
akta.pro rank

ENGAIN industry classification

Industry
Product category
Interventional Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Vascular embolization devices
  • Medical adhesives
  • Varicose vein treatment
  • Biocompatible polymers
  • Interventional medical devices

Where ENGAIN is headquartered

Location

Headquarters

HQ city
Gyeongju
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

ENGAIN business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Device Sales: ENGAIN generates revenue through the sale of medical devices including embolic agents, medical adhesives, wound closure products, and varicose vein treatment systems. Products are sold domestically in Korea and exported internationally. The company operates as both manufacturer and seller with in-house capabilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

ENGAIN product offering

Product offering

Core offering

ENGAIN researches, develops, and manufactures proprietary biocompatible polymer-based medical devices for interventional procedures, sold directly to hospitals and healthcare facilities. Its product portfolio covers vascular embolization agents (EGgel, KIPZA, EGbead), medical skin adhesives (EGglue, EasyGlue), the NUVENA NTNT varicose vein treatment system, and single-use medical consumables (Soft Fix PLUS, Bougie-36, LAPA FIX). All products are produced in-house at KGMP-certified facilities and protected by MFDS regulatory approvals.

Product overview

ENGAIN is a medical device research, development, and manufacturing company specializing in biocompatible polymer synthetic materials. The product portfolio consists of three main therapeutic areas: (1) Embolization products including EGgel, KIPZA, and EGbead for vascular embolization procedures, (2) Medical adhesives including EGglue and Easyglue for skin and epidermal closure, and (3) Varicose vein treatment systems including NUVENA using NTNT (Non-thermal, Non-tumescent) adhesive technology. Additionally, the company produces single-use medical consumables including drain tube fixation devices (Soft Fix PLUS), Bougie-36 surgical guides, and LAPA FIX laparoscopic instruments. All products are developed using proprietary polymer chemistry technology and manufactured in-house at KGMP-certified facilities.

Differentiator

Problem solved

Functional benefit

Brands

  • KIPZA: Quick-dissolving microparticles for embolization therapy, 100-4,000 μm in 5 size ranges, dissolves within 24 hours
  • EGbead
  • NUVENA
  • EGglue
  • EGgel

Products and services

  • EGgel (Vascular Embolization Prosthesis) Gelatin-based embolic prosthesis in dry powder form for intravascular embolization procedures, available in 8 particle size options from 50 to 4,000 μm in both particle and cube forms, supplied in 20 mL transparent syringes with 100 mg or 300 mg doses. For use by interventional radiologists and vascular surgeons in hospitals.
  • KIPZA (Fast-Dissolving Embolic Microparticles) Fast-degradable microparticle embolic material for vascular embolization that biodegrades within 24 hours, available in 5 size ranges from 100 to 4,000 μm in 20 mL syringes at 100, 130, or 160 mg doses. For use by interventional specialists in hospitals.
  • EGbead (Vascular Embolization Microbead) Fast-degradable microbead embolic material for vascular embolization procedures in 2 size ranges from 100 to 500 μm, supplied in 20 mL transparent syringes with 100, 200, or 300 mg doses. For use by interventional radiologists in hospitals.
  • EGglue (Medical Skin Adhesive) N-Butyl Cyanoacrylate (n-BCA) based skin adhesive for epidermal closure featuring biocompatibility and strong tensile strength, supplied as a 0.7 mL ampule with applicator in Soft/Narrow tip variants and dyed purple for easy identification. For use by clinicians in hospitals and clinics.
  • EasyGlue (이지글루) Medical Skin Adhesive Medical skin adhesive product for wound closure and skin adhesion applications, launched in October 2021 as a companion offering to EGglue.
  • NUVENA Varicose Vein Treatment System N-Butyl Cyanoacrylate (n-BCA) based lower extremity varicose vein treatment system with integrated adhesive and injection kit. Uses NTNT (Non-thermal, Non-tumescent) treatment method, developed with 100% domestic Korean technology, providing precision adhesive delivery for consistent occlusion effects. For use by vascular surgeons and interventional phlebologists in hospitals.
  • Soft Fix PLUS (Drain Tube Fixator) Silicone and hydrocolloid drain tube fixation device with one-touch locking mechanism to prevent tube twisting, sized for 7-12 Fr drainage tubes with 108 x 48 mm dressing, 25 pieces per box, sterile single-use medical device. For use in hospital surgical and drainage procedures.
  • Bougie-36 Surgical Guide Invasive disposable medical guide made of medical silicone, used during gastrectomy to confirm stomach position and guide surgical site marking. Class 2 device, 10 pieces per box, sterile. For use by surgeons in hospitals.
  • LAPA FIX Laparoscopic Instrument Disposable general endoscope instrument made of medical silicone that provides surgical space and visibility during laparoscopic procedures by lifting organs against the diaphragm using suction force. Available in 2 sizes (045, 055), 10 pieces per box. For use by laparoscopic surgeons in hospitals.

Quantifiable outcome

  • Reduced patient recovery time with NTNT (Non-thermal, Non-tumescent) varicose vein treatment
  • +1 more outcomes

Companies that use ENGAIN

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

ENGAIN technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ENGAIN partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

ENGAIN competitors and assessment

Company assessment

Broad incumbents

  • Terumo:
  • Boston Scientific: Boston Scientific acquired BTG and now markets global embolization solutions (Embozene, Onyx). Competes broadly with ENGAIN's vascular embolization portfolio across multiple geographies with established clinical evidence and distribution.

Direct peers

  • Merit Medical Systems: Merit Medical is a leading global manufacturer of embolization particles, microcatheters, and vascular interventional devices. Directly comparable to ENGAIN's EGgel/EGbead/KIPZA embolization product line serving interventional radiology procedures.
  • Cook Medical: Cook Medical manufactures embolization coils, particles, and vascular devices used in interventional radiology. Directly competes with ENGAIN's EGgel/KIPZA/EGbead embolic products in hospital interventional settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

ENGAIN social profiles

Digital presence

ENGAIN compliance and trust

Trust signal

Compliance2 records

ENGAIN financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ENGAIN leadership team

Management profile

Number of profiles

Profiles1 record

ENGAIN funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ENGAIN M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ENGAIN

What does ENGAIN do?

ENGAIN researches, develops, and manufactures proprietary biocompatible polymer-based medical devices for interventional procedures, sold directly to hospitals and healthcare facilities. Its product portfolio covers vascular embolization agents (EGgel, KIPZA, EGbead), medical skin adhesives (EGglue, EasyGlue), the NUVENA NTNT varicose vein treatment system, and single-use medical consumables (Soft Fix PLUS, Bougie-36, LAPA FIX). All products are produced in-house at KGMP-certified facilities and protected by MFDS regulatory approvals.

Is ENGAIN a public or private company?

ENGAIN is a private company. It is classified as venture growth investor backed and is currently operating.

When was ENGAIN founded?

ENGAIN was founded in 2011. It employs 11 to 50 people.

Where is ENGAIN based?

ENGAIN is headquartered in Gyeongju, South Korea, in the Asia region.

How does ENGAIN make money?

One revenue line is on record: medical Device Sales.

Who are ENGAIN's main competitors?

Broad incumbents on record are Terumo and Boston Scientific. Direct peers are Merit Medical Systems and Cook Medical.

Does ENGAIN have an API?

No public API is recorded for ENGAIN.

What industry is ENGAIN in?

ENGAIN's product category is Interventional Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales